LMW Kininogen Products

Description

LMW (Low Molecular Weight) kininogen is a major extracellular cysteine proteinase inhibitor. It is split by tissue kallikrein to produce kallidin. Kallidin, in turn, is converted into bradykinin. The kallikreinkinin system is a mediator of inflammation in humans.

Bioinformatics

Entrez	3827 Human
Uniprot	P01042 Human
Product By Gene ID	3827
Alternate Names	kininogen-1 Williams-Fitzgerald-Flaujeac factor bradykinin High molecular weight kininogen Fitzgerald factor kininogen Alpha-2-thiol proteinase inhibitor KNGHMWK BDK kininogen 1

Diseases related to LMW Kininogen

Discover more about diseases related to LMW Kininogen.

Thrombosis
Diabetes Mellitus
Diabetes Mellitus, Non-insulin-dependent
Thromboembolism
Obesity
Coronary Heart Disease
Cardiac Arrhythmia
Diabetic Nephropathy
Coronary Artery Disease
Venous Thrombosis
Edema
Venous Thromboembolism
Hemorrhage
Cerebrovascular Accident
Blood Coagulation Disorders, Inherited
Cardiac Arrest
Cytogenetic Abnormality
Sudden Cardiac Death
Dysequilibrium Syndrome
Turner Syndrome

Pathways for LMW Kininogen

View related products by pathway and learn more about each of the pathways below.

Coagulation
Glucose Homeostasis
Translation
Biological Regulation
Pathogenesis

Research Areas for LMW Kininogen

Find related products by research area and learn more about each of the different research areas below.

Apoptosis
Immunology

Bioinformatics Tool for LMW Kininogen

Discover related pathways, diseases and genes to LMW Kininogen. Need help? Read the Bioinformatics Tool Guide for instructions on using this tool.